Table 2 Clinical parameters of the PE and BE/PE patients

WBC count (*109/L)

7.61 (6.50–9.00)

56

8.34 (7.07–9.66)

169

Neutrophil count (*109/L)

4.37 (3.3–5.5)

56

4.50 (3.24–5.59)

169

Lymphocyte count (*109/L)

1.64 (1.20–2.32)

56

1.40 (1.10–1.60)

169

CRP (mg/L)

12.98 (3.03–51.21)

54

45.57 (8.44–86.97)

166

Red blood cell volume (%)

37.1 (34.2–41.3)

56

37.10 (34.9–39.7)

169

Hemoglobin (g/L)

127 (120.0–134.0)

56

126 (118.00–133.5)

169

Platelet count (*109/L)

206 (186.0–254.0)

56

201 (153.00–218.00)

169

INR

0.98 (0.91–1.10)

50

0.97 (0.912–1.06)

158

PT(s)

11.10 (10.4–12.40)

50

11.10 (10.04–12.35)

158

APTT(s)

31.20 (28.70–34.80)

50

32.50 (28.60–46.08)

158

TnI (ng/ml)

0.17 (0.01–2.11)

58

0.024 (0.005–2.11)

164

proBNP (pg/ml)

81.8 (31.20–152.94)

49

83.40 (34.90–152.94)

167

Creatine Kinase (U/L)

59.0 (42.00–81.42)

49

59.5 (36.00–81.42)

156

Lactate dehydrogenase (U/L)

195.76 (168.0–211.0)

48

195.76 (160.00–199.50)

168

Triglycerides (mmol/L)

1.21 (0.88–1.30)

49

1.15 (0.76–1.21)

168

Total cholesterol (mml/L)

4.16 (3.48–4.85)

49

4.16 (3.82–4.60)

168

Low-density lipoprotein (mmol/L)

2.66 (2.29–2.92)

49

2.66 (2.33–3.25)

168

High-density lipoprotein (mmol/L)

1.23 (1.06–1.30)

49

1.12 (0.90–1.30)

168

Homocysteine (mmol/L)

14.20 (10.65–17.2)

61

12.60 (9.70–15.60)

164

Creatinine (μmol/L)

75.60 (64.00–84.00)

53

70.650 (52.50–92.25)

148

Total bile acid (μmol/L)

5.79 (3.10–8.40)

56

5.79 (2.50–5.79)

159

Procalcitonin (ng/ml)

4.299 (1.89–6.92)

50

3.79 (0.10–6.92)

160

NLR

2.62 (1.61–3.92)

56

2.95 (2.00–4.07)

169

Carbohydrate antigen 724 (U/mL)

2.73 (1.22–3.32)

47

2.47 (1.35–5.34)

146

CH50 (U/mL)

49.20 (32.60–52.42)

45

42.30 (39.90–43.40)

130